HORIZON-MISS-2022-CANCER-01-03
HORIZON-MISS-2022-CANCER-01-03
Programme: Horizon Europe
12 projects · €71,857,021 total EU contribution (project-level) · 143 participating organizations · 26 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€71,857,021
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (26)
- France (19)
- Italy (15)
- Germany (11)
- SE (10)
- BE (9)
- Netherlands (6)
- EL (5)
- UK (5)
- CZ (4)
- IE (4)
- CH (3)
- HU (3)
- PT (3)
- RO (3)
- AT (2)
- EE (2)
- IL (2)
- LT (2)
- NO (2)
- PL (2)
- CY (1)
- DK (1)
- FI (1)
- HR (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE4 projects · ES
- NKI AVL4 projects · NL
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN3 projects · DE
- EORTC3 projects · BE
- HUS3 projects · FI
- INSTITUT GUSTAVE ROUSSY3 projects · FR
- REGIONH3 projects · DK
- SYREON3 projects · HU
- CLB2 projects · FR
- IMIM2 projects · ES
- INT2 projects · IT
- MHH2 projects · DE
Projects
Page 2 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA STREXIT2 · 101103843 | HORIZON | €4,971,875 | €108,750 | Details |
First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma CARE1 · 101104801 | HORIZON | €5,577,694 | €371,250 | Details |